These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 37443100)

  • 1. Role of N6-methyladenosine RNA modification in gastric cancer.
    Ding SQ; Zhang XP; Pei JP; Bai X; Ma JJ; Zhang CD; Dai DQ
    Cell Death Discov; 2023 Jul; 9(1):241. PubMed ID: 37443100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of N6-methyladenosine modification in the development of Parkinson's disease.
    Zhou J; Han Y; Hou R
    Front Cell Dev Biol; 2023; 11():1321995. PubMed ID: 38155838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential.
    Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
    Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
    Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia.
    Fang Z; Ding H; Han J; Fu L; Jin J; Feng W
    J Leukoc Biol; 2024 Oct; 116(4):662-671. PubMed ID: 38721720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Gene Expression Associated With the N6-Methyladenosine (m6A) Enzyme System and Its Significance in Cancer.
    Tian S; Lai J; Yu T; Li Q; Chen Q
    Front Oncol; 2020; 10():623634. PubMed ID: 33552994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.
    Fang X; Li M; Yu T; Liu G; Wang J
    Genes Dis; 2020 Dec; 7(4):585-597. PubMed ID: 33335958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma.
    He C; Teng X; Wang L; Ni M; Zhu L; Liu J; Lv W; Hu J
    Mol Biol Rep; 2023 Oct; 50(10):8691-8703. PubMed ID: 37598390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of N6-Methyladenosine Modification in Tumors.
    Zhang N; Zuo Y; Peng Y; Zuo L
    J Oncol; 2021; 2021():6461552. PubMed ID: 34858499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of N6-methyladenosine with viruses and related diseases.
    Wu F; Cheng W; Zhao F; Tang M; Diao Y; Xu R
    Virol J; 2019 Nov; 16(1):133. PubMed ID: 31711514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
    Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
    Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions.
    Imam H; Kim GW; Siddiqui A
    Front Cell Infect Microbiol; 2020; 10():584283. PubMed ID: 33330128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA N6-methyladenosine methylation and skin diseases.
    Yu Y; Lu S; Jin H; Zhu H; Wei X; Zhou T; Zhao M
    Autoimmunity; 2023 Dec; 56(1):2167983. PubMed ID: 36708146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer.
    Liu Q
    Front Genet; 2021; 12():825109. PubMed ID: 35087575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of N6-methyladenosine with viruses and virally induced diseases.
    Wu F; Cheng W; Zhao F; Tang M; Diao Y; Xu R
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1184-1201. PubMed ID: 32114429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia.
    Liu WW; Wang H; Zhu XY
    Biomark Res; 2022 Aug; 10(1):64. PubMed ID: 35999621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis.
    Ma W; Wu T
    Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1190-C1205. PubMed ID: 36036444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring m6A methylation in skin Cancer: Insights into molecular mechanisms and treatment.
    Cai M; Li X; Luan X; Zhao P; Sun Q
    Cell Signal; 2024 Dec; 124():111420. PubMed ID: 39304098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.